Increased Arthrodesis Rates in Charcot Neuroarthropathy Utilizing Distal Tibial Distraction Osteogenesis Principles.

ankle fusion corticotomy hindfoot fusion limb length discrepancy segmental bone defect tibial lengthening tibiocalcaneal tibiotalocalcaneal

Journal

Foot & ankle specialist
ISSN: 1938-7636
Titre abrégé: Foot Ankle Spec
Pays: United States
ID NLM: 101473598

Informations de publication

Date de publication:
Aug 2022
Historique:
pubmed: 5 5 2022
medline: 3 8 2022
entrez: 4 5 2022
Statut: ppublish

Résumé

Charcot neuroarthropathy of the hindfoot and ankle poses substantial challenges due to deformity, segmental bone loss, chronic infection, and difficulty with bracing. Hindfoot or ankle arthrodesis is often employed at high rates of complications and nonunion. This study reports 15 consecutive patients with Charcot neuroarthropathy who underwent tibiotalocalcaneal or tibiocalcaneal fusion with simultaneous distal tibial distraction osteogenesis with a mean follow-up period of 20.2 ± 5.66 months. Arthrodesis rate was 93.3% (14 patients) with mean time to fusion of 4.75 ± 3.4 months. One hypertrophic nonunion occurred at the arthrodesis site. Complete consolidation of 4 cortices was achieved at the distraction site in 93.3% of patients (14 patients) with a mean duration to consolidation of 9.8 ± 3.3 months. One patient experienced hypertrophic nonunion at the regeneration site. The authors report a technique to enhance arthrodesis rates in Charcot neuroarthropathy by combining distal tibial distraction osteogenesis with simultaneous tibiotalocalcaneal or tibiocalcaneal arthrodesis for hindfoot fusion and salvage. Distraction osteogenesis supports enhanced vascularity to the arthrodesis site.

Identifiants

pubmed: 35506193
doi: 10.1177/19386400221087822
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

394-408

Auteurs

Noman A Siddiqui (NA)

International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland.
Division of Podiatry, Northwest Hospital, Randallstown, Maryland.

Kelsey J Millonig (KJ)

International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland.

Brittany E Mayer (BE)

Potomac Podiatry Group PLLC, Crofton, Maryland.
Potomac Podiatry Group PLLC, Woodbridge, Virginia.

Jessica N Fink (JN)

Physicians Footcare, Florence, South Carolina.

Philip K McClure (PK)

International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland.

Christopher Bibbo (C)

International Center for Limb Lengthening, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH